Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment-Reference-Cited by-同舟云学术

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment

Published:2021-03-02 Issue:4 Volume:54 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif

Author:

Liu Guihong¹^ORCID,Chen Tao²,Ding Zhenyu³,Wang Yang¹,Wei Yuquan¹,Wei Xiawei¹^ORCID

Affiliation:

1. Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy National Clinical Research Center for Geriatrics West China Hospital Sichuan University Chengdu China

2. Cardiology Department Chengdu NO.7 People’s Hospital Chengdu Tumor Hospital Chengdu China

3. Department of Biotherapy State Key Laboratory of Biotherapy Cancer Center West China HospitalSichuan University Chengdu China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13009

Reference256 articles.

1. Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

2. Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial

3. Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

4. HER2-positive breast cancer

5. Fibroblast growth factor receptors as treatment targets in clinical oncology

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies;Bioorganic Chemistry;2024-11

2. Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance;Cancers;2024-09-07

3. Insights into the post-translational modifications in heart failure;Ageing Research Reviews;2024-09

4. Application of Pro-angiogenic Biomaterials in Myocardial Infarction;ACS Omega;2024-08-27

5. The potential of lenvatinib in breast cancer therapy;Medical Oncology;2024-08-22